Stay updated on Bispecific Antibody MCLA-158 Clinical Trial

Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' to the study's conditions.
    Difference
    0.0%
    Check dated 2026-03-29T00:45:43.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.3 to v3.5.0; no changes to the study content.
    Difference
    0.0%
    Check dated 2026-03-21T19:49:51.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This represents a minor version update with no substantive content updates.
    Difference
    0.0%
    Check dated 2026-03-07T06:17:23.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Gastric cancer has been added to the Conditions list. The Genetic and Rare Diseases Information Center is now listed as a resource, and the page revision was updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T13:41:21.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Merus N.V. was removed and Merus B.V. was added as the sponsor. The page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-06T09:11:57.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Glossary toggle controls were added (Show glossary, Hide glossary) and new metadata items Last Update Submitted that Met QC Criteria and No FEAR Act Data were introduced, along with a revision note Revision: v3.4.0. The older variants Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.2%
    Check dated 2026-01-22T18:02:37.000Z thumbnail image

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.